Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Safety of Meloxicam in Patients with Heart Disease

Primary Guideline Recommendations

  • The American College of Cardiology/American Heart Association recommends that NSAIDs (except aspirin) should not be initiated and should be discontinued during hospitalization for acute coronary syndromes because of increased risk of major adverse cardiovascular events (MACE), representing a Class III: Harm recommendation, meaning NSAIDs are potentially harmful and should not be used 1, 2
  • The American College of Cardiology/American Heart Association classifies NSAID use as Class III: Harm, noting that NSAIDs should be discontinued at presentation with acute cardiovascular conditions due to increased risks of mortality, reinfarction, hypertension, heart failure, and myocardial rupture 2

Cardiovascular Risk Profile of Meloxicam

  • All NSAIDs, including meloxicam, carry a risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal, with the risk increasing with duration of use and being substantially higher in patients with existing cardiovascular disease 3
  • The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis recommends limiting non-selective NSAIDs to 7 days maximum in patients with increased cardiovascular risk, but notes this still carries substantial risk 5

Specific Concerns in Heart Disease Patients

  • NSAIDs can worsen heart failure exacerbation by promoting sodium and water retention, directly worsening heart failure 6
  • NSAIDs can increase systolic blood pressure and impair blood pressure control 7, 6
  • NSAIDs can impair renal function in patients with decreased effective circulating volume, common in heart disease 6
  • The combination of NSAIDs and aspirin substantially increases bleeding risk 7
  • The American College of Cardiology/American Heart Association recommends a stepped-care approach prioritizing safer alternatives, including acetaminophen (up to 4g daily in divided doses) as initial therapy, topical NSAIDs (diclofenac gel/patch) for localized pain, and tramadol for moderate pain 7, 8, 9
  • Short-term narcotic analgesics (low-dose oral opioids with monitoring) and nonacetylated salicylates may be considered as second-line options if first-line alternatives are inadequate 7, 8, 6

Critical Clinical Pitfalls to Avoid

  • The American College of Cardiology/American Heart Association guidelines make no distinction for short-term use in heart disease patients, and meloxicam should not be used in patients with heart failure due to fluid retention risk 1, 6, 9
  • Combining meloxicam with aspirin may not provide adequate thrombotic protection, and meloxicam should not be used in elderly patients (≥75 years) with heart disease due to compounded cardiovascular risk 7, 8, 5, 9

REFERENCES

3

Management of Basilar Artery Aneurysm with NSAIDs [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

NSAID Use in Older Adults [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025